Aprea Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell APRE and other ETFs, options, and stocks.

About APRE

Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of cancer therapeutics. It is involved in the development and commercialization of novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. 

CEO
Oren Gilad
CEOOren Gilad
Employees
8
Employees8
Headquarters
Doylestown, Pennsylvania
HeadquartersDoylestown, Pennsylvania
Founded
2002
Founded2002
Employees
8
Employees8

APRE Key Statistics

Market cap
10.52M
Market cap10.52M
Price-Earnings ratio
-0.43
Price-Earnings ratio-0.43
Dividend yield
Dividend yield
Average volume
175.42K
Average volume175.42K
High today
$0.9424
High today$0.9424
Low today
$0.87
Low today$0.87
Open price
$0.8798
Open price$0.8798
Volume
113.26K
Volume113.26K
52 Week high
$2.79
52 Week high$2.79
52 Week low
$0.548
52 Week low$0.548

Stock Snapshot

The current Aprea Therapeutics(APRE) stock price is $0.92, with a market capitalization of 10.52M. The stock trades at a price-to-earnings (P/E) ratio of -0.43.

On 2026-03-05, Aprea Therapeutics(APRE) stock moved within a range of $0.87 to $0.94. With shares now at $0.92, the stock is trading +5.6% above its intraday low and -2.5% below the session's peak.

Trading volume for Aprea Therapeutics(APRE) stock has reached 113.26K, versus its average volume of 175.42K.

Over the past 52 weeks, Aprea Therapeutics(APRE) stock has traded between a high of $2.79 and a low of $0.55.

Over the past 52 weeks, Aprea Therapeutics(APRE) stock has traded between a high of $2.79 and a low of $0.55.

People also own

Based on the portfolios of people who own APRE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.